Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

SCID genotype and 6-month post-transplant CD4 count predict survival and immune recovery: a PIDTC retrospective study.

Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen A, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD.

Blood. 2018 Aug 28. pii: blood-2018-03-840702. doi: 10.1182/blood-2018-03-840702. [Epub ahead of print]

PMID:
30154114
2.

The conceptual structure of face impressions.

Stolier RM, Hehman E, Keller MD, Walker M, Freeman JB.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9210-9215. doi: 10.1073/pnas.1807222115. Epub 2018 Aug 23.

PMID:
30139918
3.

Expression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell Carcinomas.

Langer R, Neppl C, Keller MD, Schmid RA, Tschan MP, Berezowska S.

Cancers (Basel). 2018 Aug 21;10(9). pii: E281. doi: 10.3390/cancers10090281.

4.

Provider practices in screening for mental health concerns in caregivers of patients with primary immunodeficiency.

Page A, Jacobs MB, Herrera NA, Henderson TS, Scalchunes C, Keller MD, Herbert LJ.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):254-256. doi: 10.1016/j.anai.2018.05.015. Epub 2018 May 23. No abstract available.

PMID:
29802981
5.

Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency.

Miller HK, Hanley PJ, Lang H, Lazarski CA, Chorvinsky EA, McCormack S, Roesch L, Albihani S, Dean M, Hoq F, Adams RH, Bollard CM, Keller MD.

Biol Blood Marrow Transplant. 2018 May 9. pii: S1083-8791(18)30252-0. doi: 10.1016/j.bbmt.2018.04.030. [Epub ahead of print]

PMID:
29753156
6.

Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular Medicine.

Keller MD, Notarangelo LD, Malech HL.

J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S40-S44. doi: 10.1093/jpids/piy011.

7.

Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.

McLaughlin LP, Bollard CM, Keller MD.

Front Immunol. 2018 Mar 19;9:556. doi: 10.3389/fimmu.2018.00556. eCollection 2018. Review.

8.

Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.

McCormack SE, Cruz CRY, Wright KE, Powell AB, Lang H, Trimble C, Keller MD, Fuchs E, Bollard CM.

Cytotherapy. 2018 Mar;20(3):385-393. doi: 10.1016/j.jcyt.2017.11.010. Epub 2018 Jan 10.

PMID:
29331266
9.

Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases.

Keller MD, Neppl C, Irmak Y, Hall SR, Schmid RA, Langer R, Berezowska S.

Mod Pathol. 2018 Jan;31(1):101-110. doi: 10.1038/modpathol.2017.111. Epub 2017 Sep 8.

PMID:
28884747
10.

Improving transplantation for IL2RG/JAK3 SCID.

Keller MD.

Blood. 2017 Apr 13;129(15):2049-2050. doi: 10.1182/blood-2017-03-770974. No abstract available.

11.

Biallelic mutations in IRF8 impair human NK cell maturation and function.

Mace EM, Bigley V, Gunesch JT, Chinn IK, Angelo LS, Care MA, Maisuria S, Keller MD, Togi S, Watkin LB, LaRosa DF, Jhangiani SN, Muzny DM, Stray-Pedersen A, Coban Akdemir Z, Smith JB, Hernández-Sanabria M, Le DT, Hogg GD, Cao TN, Freud AG, Szymanski EP, Savic S, Collin M, Cant AJ, Gibbs RA, Holland SM, Caligiuri MA, Ozato K, Paust S, Doody GM, Lupski JR, Orange JS.

J Clin Invest. 2017 Jan 3;127(1):306-320. doi: 10.1172/JCI86276. Epub 2016 Nov 28.

12.

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.

Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G, Rivera SA, Chramiec AG, Pronier E, Bastian L, Keller MD, Tovbin D, Loizou E, Weinstein AR, Gonzalez AR, Lieu YK, Rowe JM, Pastore F, McKenney AS, Krivtsov AV, Sperr WR, Cross JR, Mason CE, Tallman MS, Arcila ME, Abdel-Wahab O, Armstrong SA, Kubicek S, Staber PB, Gönen M, Paietta EM, Melnick AM, Nimer SD, Mukherjee S, Levine RL.

Nat Med. 2016 Dec;22(12):1488-1495. doi: 10.1038/nm.4210. Epub 2016 Nov 14.

13.

Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes.

McLaughlin LP, Lang H, Williams E, Wright KE, Powell A, Cruz CR, Colberg-Poley AM, Barese C, Hanley PJ, Bollard CM, Keller MD.

Cytotherapy. 2016 Dec;18(12):1515-1524. doi: 10.1016/j.jcyt.2016.08.010. Epub 2016 Sep 28.

14.

Performance in noise: Impact of reduced speech intelligibility on Sailor performance in a Navy command and control environment.

Keller MD, Ziriax JM, Barns W, Sheffield B, Brungart D, Thomas T, Jaeger B, Yankaskas K.

Hear Res. 2017 Jun;349:55-66. doi: 10.1016/j.heares.2016.10.007. Epub 2016 Oct 19.

15.

Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".

LaFave LM, Béguelin W, Koche R, Teater M, Spitzer B, Chramiec A, Papalexi E, Keller MD, Hricik T, Konstantinoff K, Micol JB, Durham B, Knutson SK, Campbell JE, Blum G, Shi X, Doud EH, Krivtsov AV, Chung YR, Khodos I, de Stanchina E, Ouerfelli O, Adusumilli PS, Thomas PM, Kelleher NL, Luo M, Keilhack H, Abdel-Wahab O, Melnick A, Armstrong SA, Levine RL.

Nat Med. 2016 Jun 7;22(6):578-9. doi: 10.1038/nm.4094. No abstract available.

PMID:
27270773
16.

Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.

Keller MD, Pandey R, Li D, Glessner J, Tian L, Henrickson SE, Chinn IK, Monaco-Shawver L, Heimall J, Hou C, Otieno FG, Jyonouchi S, Calabrese L, van Montfrans J, Orange JS, Hakonarson H.

J Allergy Clin Immunol. 2016 Aug;138(2):544-550.e4. doi: 10.1016/j.jaci.2016.01.018. Epub 2016 Mar 23.

17.

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes.

Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, Rooney CM, Hanson IC, Krance RA, Shpall EJ, Cruz CR, Amrolia P, Lucchini G, Bunin N, Heimall J, Klein OR, Gennery AR, Slatter MA, Vickers MA, Orange JS, Heslop HE, Bollard CM, Keller MD.

J Allergy Clin Immunol. 2016 May;137(5):1498-1505.e1. doi: 10.1016/j.jaci.2015.12.1311. Epub 2016 Feb 24.

18.

Laser induced mortality of Anopheles stephensi mosquitoes.

Keller MD, Leahy DJ, Norton BJ, Johanson T, Mullen ER, Marvit M, Makagon A.

Sci Rep. 2016 Feb 18;6:20936. doi: 10.1038/srep20936.

19.

Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.

Guryanova OA, Lieu YK, Garrett-Bakelman FE, Spitzer B, Glass JL, Shank K, Martinez AB, Rivera SA, Durham BH, Rapaport F, Keller MD, Pandey S, Bastian L, Tovbin D, Weinstein AR, Teruya-Feldstein J, Abdel-Wahab O, Santini V, Mason CE, Melnick AM, Mukherjee S, Levine RL.

Leukemia. 2016 May;30(5):1133-42. doi: 10.1038/leu.2015.358. Epub 2015 Dec 29.

20.

Loss of BAP1 function leads to EZH2-dependent transformation.

LaFave LM, Béguelin W, Koche R, Teater M, Spitzer B, Chramiec A, Papalexi E, Keller MD, Hricik T, Konstantinoff K, Micol JB, Durham B, Knutson SK, Campbell JE, Blum G, Shi X, Doud EH, Krivtsov AV, Chung YR, Khodos I, de Stanchina E, Ouerfelli O, Adusumilli PS, Thomas PM, Kelleher NL, Luo M, Keilhack H, Abdel-Wahab O, Melnick A, Armstrong SA, Levine RL.

Nat Med. 2015 Nov;21(11):1344-9. doi: 10.1038/nm.3947. Epub 2015 Oct 5.

21.

Quantification of β-Amyloidosis and rCBF with Dedicated PET, 7 T MR Imaging, and High-Resolution Microscopic MR Imaging at 16.4 T in APP23 Mice.

Maier FC, Keller MD, Bukala D, Bender B, Mannheim JG, Brereton IM, Galloway GJ, Pichler BJ.

J Nucl Med. 2015 Oct;56(10):1593-9. doi: 10.2967/jnumed.115.159350. Epub 2015 Aug 6.

22.

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.

Meyer SC, Keller MD, Chiu S, Koppikar P, Guryanova OA, Rapaport F, Xu K, Manova K, Pankov D, O'Reilly RJ, Kleppe M, McKenney AS, Shih AH, Shank K, Ahn J, Papalexi E, Spitzer B, Socci N, Viale A, Mandon E, Ebel N, Andraos R, Rubert J, Dammassa E, Romanet V, Dölemeyer A, Zender M, Heinlein M, Rampal R, Weinberg RS, Hoffman R, Sellers WR, Hofmann F, Murakami M, Baffert F, Gaul C, Radimerski T, Levine RL.

Cancer Cell. 2015 Jul 13;28(1):15-28. doi: 10.1016/j.ccell.2015.06.006.

23.

Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.

Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cooke KR.

Stem Cells. 2015 Feb;33(2):601-14. doi: 10.1002/stem.1867.

24.

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.

Melenhorst JJ, Castillo P, Hanley PJ, Keller MD, Krance RA, Margolin J, Leen AM, Heslop HE, Barrett AJ, Rooney CM, Bollard CM.

Mol Ther. 2015 Jan;23(1):179-83. doi: 10.1038/mt.2014.192. Epub 2014 Sep 30.

25.

Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis.

Meyer SC, Keller MD, Woods BA, LaFave LM, Bastian L, Kleppe M, Bhagwat N, Marubayashi S, Levine RL.

Blood. 2014 Oct 2;124(14):2280-4. doi: 10.1182/blood-2014-03-560441. Epub 2014 Aug 12.

26.

Herpes zoster duplex bilateralis in an immunocompetent adolescent boy: a case report and literature review.

Yan C, Laguna BA, Marlowe LE, Keller MD, Treat JR.

Pediatr Dermatol. 2014 May-Jun;31(3):341-4. doi: 10.1111/pde.12302. Epub 2014 Mar 19. Review.

PMID:
24641775
27.
28.

Vocoder simulations of highly focused cochlear stimulation with limited dynamic range and discriminable steps.

Stafford RC, Stafford JW, Wells JD, Loizou PC, Keller MD.

Ear Hear. 2014 Mar-Apr;35(2):262-70. doi: 10.1097/AUD.0b013e3182a768e8.

PMID:
24322978
29.

Analytical approaches for determining heat distributions and thermal criteria for infrared neural stimulation.

Norton BJ, Bowler MA, Wells JD, Keller MD.

J Biomed Opt. 2013 Sep;18(9):098001. doi: 10.1117/1.JBO.18.9.098001.

PMID:
24002195
30.

Hippocampal volume and cell density changes in a mouse model of human genetic epilepsy.

Richards KL, Kurniawan ND, Yang Z, Kim TH, Keller MD, Low J, Ullmann JF, Cole S, Foong S, Galloway GJ, Reid CA, Paxinos G, Reutens DC, Petrou S.

Neurology. 2013 Mar 26;80(13):1240-6. doi: 10.1212/WNL.0b013e31828970ec. Epub 2013 Mar 6.

PMID:
23468543
31.

Immunodeficiency in patients with 49,XXXXY chromosomal variation.

Keller MD, Sadeghin T, Samango-Sprouse C, Orange JS.

Am J Med Genet C Semin Med Genet. 2013 Feb 15;163C(1):50-4. doi: 10.1002/ajmg.c.31348. Epub 2013 Jan 23.

32.

Severe combined immunodeficiency resulting from mutations in MTHFD1.

Keller MD, Ganesh J, Heltzer M, Paessler M, Bergqvist AG, Baluarte HJ, Watkins D, Rosenblatt DS, Orange JS.

Pediatrics. 2013 Feb;131(2):e629-34. doi: 10.1542/peds.2012-0899. Epub 2013 Jan 6.

PMID:
23296427
33.

Chipping away at a mountain: genomic studies in common variable immunodeficiency.

Keller MD, Jyonouchi S.

Autoimmun Rev. 2013 Apr;12(6):687-9. doi: 10.1016/j.autrev.2012.10.017. Epub 2012 Nov 29. Review.

34.

Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model.

Kerbler GM, Hamlin AS, Pannek K, Kurniawan ND, Keller MD, Rose SE, Coulson EJ.

Neuroimage. 2013 Feb 1;66:133-41. doi: 10.1016/j.neuroimage.2012.10.075. Epub 2012 Nov 2.

PMID:
23128077
35.

Segmentation of the C57BL/6J mouse cerebellum in magnetic resonance images.

Ullmann JF, Keller MD, Watson C, Janke AL, Kurniawan ND, Yang Z, Richards K, Paxinos G, Egan GF, Petrou S, Bartlett P, Galloway GJ, Reutens DC.

Neuroimage. 2012 Sep;62(3):1408-14. doi: 10.1016/j.neuroimage.2012.05.061. Epub 2012 May 30.

PMID:
22658976
36.

Severe malnutrition resulting from use of rice milk in food elimination diets for atopic dermatitis.

Keller MD, Shuker M, Heimall J, Cianferoni A.

Isr Med Assoc J. 2012 Jan;14(1):40-2.

37.

Development of a spatially offset Raman spectroscopy probe for breast tumor surgical margin evaluation.

Keller MD, Vargis E, de Matos Granja N, Wilson RH, Mycek MA, Kelley MC, Mahadevan-Jansen A.

J Biomed Opt. 2011 Jul;16(7):077006. doi: 10.1117/1.3600708.

38.

Segmentation of the mouse hippocampal formation in magnetic resonance images.

Richards K, Watson C, Buckley RF, Kurniawan ND, Yang Z, Keller MD, Beare R, Bartlett PF, Egan GF, Galloway GJ, Paxinos G, Petrou S, Reutens DC.

Neuroimage. 2011 Oct 1;58(3):732-40. doi: 10.1016/j.neuroimage.2011.06.025. Epub 2011 Jun 17.

PMID:
21704710
39.

Effect of normal variations on disease classification of Raman spectra from cervical tissue.

Vargis E, Kanter EM, Majumder SK, Keller MD, Beaven RB, Rao GG, Mahadevan-Jansen A.

Analyst. 2011 Jul 21;136(14):2981-7. doi: 10.1039/c0an01020k. Epub 2011 Jun 13.

PMID:
21666910
40.

Nuclear magnetic resonance-based metabonomic study of early time point laminitis in an oligofructose-overload model.

Keller MD, Pollitt CC, Marx UC.

Equine Vet J. 2011 Nov;43(6):737-43. doi: 10.1111/j.2042-3306.2010.00336.x. Epub 2011 Mar 15.

PMID:
21496096
41.

Hypohidrotic ectodermal dysplasia and immunodeficiency with coincident NEMO and EDA mutations.

Keller MD, Petersen M, Ong P, Church J, Risma K, Burham J, Jain A, Stiehm ER, Hanson EP, Uzel G, Deardorff MA, Orange JS.

Front Immunol. 2011 Nov 8;2:61. doi: 10.3389/fimmu.2011.00061. eCollection 2011.

42.

Monte Carlo model of spatially offset Raman spectroscopy for breast tumor margin analysis.

Keller MD, Wilson RH, Mycek MA, Mahadevan-Jansen A.

Appl Spectrosc. 2010 Jun;64(6):607-14. doi: 10.1366/000370210791414407.

PMID:
20537228
43.

Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis.

Keller MD, Majumder SK, Kelley MC, Meszoely IM, Boulos FI, Olivares GM, Mahadevan-Jansen A.

Lasers Surg Med. 2010 Jan;42(1):15-23. doi: 10.1002/lsm.20865.

PMID:
20077490
44.

Application of Raman spectroscopy for cervical dysplasia diagnosis.

Kanter EM, Vargis E, Majumder S, Keller MD, Woeste E, Rao GG, Mahadevan-Jansen A.

J Biophotonics. 2009 Feb;2(1-2):81-90. doi: 10.1002/jbio.200910001.

45.

Spatially offset Raman spectroscopy of layered soft tissues.

Keller MD, Majumder SK, Mahadevan-Jansen A.

Opt Lett. 2009 Apr 1;34(7):926-8.

PMID:
19340173
46.

Detecting temporal and spatial effects of epithelial cancers with Raman spectroscopy.

Keller MD, Kanter EM, Lieber CA, Majumder SK, Hutchings J, Ellis DL, Beaven RB, Stone N, Mahadevan-Jansen A.

Dis Markers. 2008;25(6):323-37.

47.

Comparison of autofluorescence, diffuse reflectance, and Raman spectroscopy for breast tissue discrimination.

Majumder SK, Keller MD, Boulos FI, Kelley MC, Mahadevan-Jansen A.

J Biomed Opt. 2008 Sep-Oct;13(5):054009. doi: 10.1117/1.2975962.

PMID:
19021389
48.

Combined Raman spectroscopy and optical coherence tomography device for tissue characterization.

Patil CA, Bosschaart N, Keller MD, van Leeuwen TG, Mahadevan-Jansen A.

Opt Lett. 2008 May 15;33(10):1135-7.

49.

The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).

Keller MD, Chen DF, Condron SA, Liu N, Reinsmoen NL, Buckley RH.

J Clin Immunol. 2007 Jan;27(1):109-16. Epub 2006 Dec 27. Erratum in: J Clin Immunol. 2007 Nov;27(6):659.

PMID:
17191149
50.

T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

Roberts JL, Lauritsen JP, Cooney M, Parrott RE, Sajaroff EO, Win CM, Keller MD, Carpenter JH, Carabana J, Krangel MS, Sarzotti M, Zhong XP, Wiest DL, Buckley RH.

Blood. 2007 Apr 15;109(8):3198-206. Epub 2006 Dec 14.

Supplemental Content

Loading ...
Support Center